{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T23:24:57Z","timestamp":1794180297590,"version":"4.8.0"},"reference-count":53,"publisher":"SAGE Publications","issue":"3_suppl","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Foot &amp; Ankle Specialist"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:p>Interest in adipose-derived orthobiologics and extracellular vesicles (EVs) has expanded as clinicians seek minimally invasive treatments for musculoskeletal disorders. However, culture-expanded adipose-derived stromal cells, stromal vascular fraction, microfragmented adipose tissue (MFAT), and isolated EVs are biologically and regulatorily distinct products. This narrative review summarizes their biological rationale, processing, clinical evidence, regulatory considerations, and potential application in foot and ankle surgery. Randomized studies in knee osteoarthritis suggest that MFAT may provide symptomatic improvement, but it has not consistently demonstrated superiority over other orthobiologic injections, and the certainty of evidence remains low. Preclinical EV studies provide biological plausibility for effects on tendon healing, tendon-to-bone integration, and cartilage repair. However, substantial heterogeneity in cellular source, preparation, dose, and experimental model limits translation. Human orthopaedic EV evidence remains confined to early studies in knee osteoarthritis using placental or umbilical cord derived products, with limited and conflicting evidence of efficacy and no completed studies specific to the foot and ankle. No adipose-derived regenerative medicine or EV product is Food and Drug Administration-approved for an orthopaedic indication. Current evidence therefore does not support routine clinical use or claims of tissue regeneration. Standardized product characterization and well-designed comparative trials are required to establish safety, efficacy, and appropriate clinical applications.<\/jats:p>","DOI":"10.1177\/19386400261497293","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T08:34:08Z","timestamp":1791794048000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adipose-Derived Orthobiologics and Extracellular Vesicles in Foot and Ankle Surgery: Current Evidence and Clinical Limitations"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-1621","authenticated-orcid":false,"given":"Alexander","family":"Tham","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Health, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Health, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Butler","sequence":"additional","affiliation":[{"name":"Albany Medical Center, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Health, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel P.","family":"Mercer","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Health, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Lezak","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Health, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Mojica","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Health, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefko","family":"Charalambous","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Health, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7286-0689","authenticated-orcid":false,"given":"John G.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Health, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/19386400261458581"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/19386400261465086"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2013.02.006"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.19-0166"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20581-1"},{"key":"e_1_3_2_7_2","volume-title":"Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. Guidance for Industry and Food and Drug Administration Staff","author":"US Food Drug Administration","year":"2020","unstructured":"US Food Drug Administration. Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. Guidance for Industry and Food and Drug Administration Staff. U.S. Food and Drug Administration; 2020."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212373"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxad032"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06930-4"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144719"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8810813"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0000000000006748"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.35705"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000121425.42966.F1"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000234610.81672.e7"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1672155"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40778-016-0053-5"},{"issue":"221","key":"e_1_3_2_20_2","first-page":"54290","article-title":"Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use","volume":"82","author":"Food Drug Administration","year":"2017","unstructured":"Food Drug Administration. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use. Fed Reg. 2017;82(221):54290-54292.","journal-title":"Fed Reg"},{"key":"e_1_3_2_21_2","volume-title":"Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes","author":"US Food Drug Administration","year":"2020","unstructured":"US Food Drug Administration. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. US Food Drug Administration; 2020."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/23259671241233916"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/23259671221120678"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/03635465221115821"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2024.08.037"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/03635465241249940"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-021-05093-3"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/1947603520946364"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.3390\/app13158983"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/0363546514541778"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40634-016-0048-2"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2016.01.020"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12306-023-00798-7"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-017-4479-9"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c08774"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2020.07.001"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1960-x"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-018-0264-y"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2020.01.051"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/03635465221108972"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/0363546520908847"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/03635465211072227"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00234-1"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-019-00330-x"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/jfb14040203"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-1004-0"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.17133"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15376-8"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/03635465211068129"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-024-07979-w"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-03088-x"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06623-y"},{"key":"e_1_3_2_54_2","volume-title":"Public Safety Notification on Exosome Products","author":"US Food Drug Administration","year":"2019","unstructured":"US Food Drug Administration. Public Safety Notification on Exosome Products. US Food and Drug Administration; 2019."}],"container-title":["Foot &amp; Ankle Specialist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19386400261497293","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19386400261497293","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19386400261497293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T23:20:13Z","timestamp":1794180013000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19386400261497293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":53,"journal-issue":{"issue":"3_suppl","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10.1177\/19386400261497293"],"URL":"https:\/\/doi.org\/10.1177\/19386400261497293","relation":{},"ISSN":["1938-6400","1938-7636"],"issn-type":[{"value":"1938-6400","type":"print"},{"value":"1938-7636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]}}}